Skip to search formSkip to main contentSkip to account menu

Amsacrine

Known as: Amsacrine [Chemical/Ingredient], meta-AMSA, 4'-(9-Acridinylamino)methanesulfon-meta-anisidide 
An aminoacridine derivative with potential antineoplastic activity. Although its mechanism of action is incompletely defined, amsacrine may… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1987
1987
Benzisoquinolinedione (nafidimide; NSC 308847) is an investigational drug currently in phase I clinical testing. We have studied… 
1985
1985
Treatment of mouse leukemia L1210 cells with the polyamine biosynthesis inhibitor alpha-difluoromethylornithine (DFMO) increased… 
Highly Cited
1984
Highly Cited
1984
Treatment of mammalian cells with DNA intercalating agents produces protein-associated DNA strand breaks. These breaks have been… 
1984
1984
4'-(9-Acridinylamino)methanesulfon-m-anisidide (m-AMSA) is metabolized by a hepatic microsomal enzyme system composed of rat… 
1983
1983
The synthesis and biological evaluation of a series of 3-substituted 5-carboxamido derivatives of amsacrine (m-AMSA) are… 
1982
1982
AMSA produced changes on echocardiograms of 18 of 27 patients. Seven patients developed clinical congestive heart failure. The… 
Highly Cited
1981
Highly Cited
1981
In an investigation of the structure-activity relationships in the 4'-(9-acridinylamino)methanesulfonanilide (AMSA) tumor… 
1981
1981
Conjugation and cleavage products in the thiolytic metabolism of the anticancer drug 4'-(9-acridinylamino)methanesulfon-m… 
1980
1980
Forty-one pediatric patients with advanced cancer (24 with acute leukemia and 17 with diverse solid tumors) received 74 courses…